Randomized Comparison of Prophylactic Antidiarrheal Treatment Versus No Prophylactic Antidiarrheal Treatment in Patients Receiving CPT-11 (Irinotecan) for Advanced 5-FU-Resistant Colorectal Cancer: An Open-Label Multicenter Phase II Study
Marc Ychou, Jean Yves Douillard, Philippe Rougier, Antoine Adenis, Mireille Mousseau, Patrick Dufour, J. L. Wendling, F. Burki, Dominique Mignard et Michel Marty
American journal of clinical oncology, Vol.23(2), pp.143-148
Randomized Comparison of Prophylactic Antidiarrheal Treatment Versus No Prophylactic Antidiarrheal Treatment in Patients Receiving CPT-11 (Irinotecan) for Advanced 5-FU-Resistant Colorectal Cancer
Créateurs - sans rôle
Marc Ychou
Jean Yves Douillard
Philippe Rougier
Antoine Adenis
Mireille Mousseau
Patrick Dufour
J. L. Wendling
F. Burki
Dominique Mignard
Michel Marty
Détails de publication
American journal of clinical oncology, Vol.23(2), pp.143-148
Nombre de pages
6
Identifiants
99140048709311
Unité académique
Institut de Recherche en Cancérologie de Montpellier - IRCM